Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000193013 | SCV000247232 | pathogenic | DYRK1A-related intellectual disability syndrome | 2015-02-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000413642 | SCV000490518 | pathogenic | not provided | 2024-04-20 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25920557, 25363760, 28053047, 28191890, 31332282, 31981491, 28714951, 35982159, 33057194, 35982160, 37595579, 31785789, 34345024, 31440721) |
Baylor Genetics | RCV000193013 | SCV000807305 | pathogenic | DYRK1A-related intellectual disability syndrome | 2017-09-01 | criteria provided, single submitter | clinical testing | This nonsense mutation is categorized as deleterious according to ACMG guidelines (PMID:18414213). It was found in three unrelated probands in our laboratory, twice confirmed de novo. Patients showed intellectual disability, microcephaly, and two also dysmorphic features and seizures |
Labcorp Genetics |
RCV000193013 | SCV000822250 | pathogenic | DYRK1A-related intellectual disability syndrome | 2023-06-11 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 162158). This premature translational stop signal has been observed in individual(s) with syndromic intellectual disability (PMID: 25920557, 28053047). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg437*) in the DYRK1A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DYRK1A are known to be pathogenic (PMID: 25944381). |
Ambry Genetics | RCV001267631 | SCV001445813 | pathogenic | Inborn genetic diseases | 2019-11-07 | criteria provided, single submitter | clinical testing | |
Centre de Biologie Pathologie Génétique, |
RCV000193013 | SCV002559159 | pathogenic | DYRK1A-related intellectual disability syndrome | criteria provided, single submitter | clinical testing | ||
Greenwood Genetic Center Diagnostic Laboratories, |
RCV000149564 | SCV000196063 | pathogenic | Seizure; Feeding difficulties; Deeply set eye; Microcephaly; Intellectual disability; Absent or delayed speech development | 2014-09-09 | no assertion criteria provided | clinical testing | |
Genome |
RCV001265301 | SCV001443418 | pathogenic | Complex neurodevelopmental disorder | 2018-08-13 | no assertion criteria provided | provider interpretation | Submission from Simons Searchlight facilitated by GenomeConnect. Variant interpreted by the Simons Searchlight team most recently on 2018-08-13 and interpreted as Pathogenic. Variant was initially reported on 2017-03-10 by GTR ID of laboratory name 1006. The reporting laboratory might also submit to ClinVar. |